Partners Alta - Net Worth and Insider Trading

Partners Alta Net Worth

The estimated net worth of Partners Alta is at least $4,842 dollars as of 2024-11-13. Partners Alta is the of Raptor Pharmaceutical Corp and owns about 538 shares of Raptor Pharmaceutical Corp (RPTP) stock worth over $4,842. Details can be seen in Partners Alta's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Partners Alta has not made any transactions after 2009-09-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Partners Alta

Partners Alta Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Partners Alta owns 6 companies in total, including Raptor Pharmaceutical Corp (RPTP) , Dynavax Technologies Corp (DVAX) , and Cutera Inc (CUTR) among others .

Click here to see the complete history of Partners Alta’s form 4 insider trades.

Insider Ownership Summary of Partners Alta

Ticker	Comapny	Transaction Date	Type of Owner
RPTP	Raptor Pharmaceutical Corp	2009-09-08	other: Former 10% owner
DVAX	Dynavax Technologies Corp	2005-02-23	other: No longer 10% Owner
CUTR	Cutera Inc	2004-03-31	10 percent owner
		2004-03-22	10 percent owner
		2004-02-19	10 percent owner
		2003-08-27	10 percent owner

Partners Alta Latest Holdings Summary

Partners Alta currently owns a total of 1 stock. Partners Alta owns 538 shares of Raptor Pharmaceutical Corp (RPTP) as of September 8, 2009, with a value of $4,842.

Latest Holdings of Partners Alta

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
RPTP	Raptor Pharmaceutical Corp	2009-09-08	538	9.00	4,842

Holding Weightings of Partners Alta

Partners Alta Form 4 Trading Tracker

According to the SEC Form 4 filings, Partners Alta has made a total of 0 transactions in Raptor Pharmaceutical Corp (RPTP) over the past 5 years. The most-recent trade in Raptor Pharmaceutical Corp is the sale of 42,225 shares on September 8, 2009, which brought Partners Alta around $157,924.

Insider Trading History of Partners Alta

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Partners Alta Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Partners Alta Ownership Network

Ownership Network List of Partners Alta

No Data

Ownership Network Relation of Partners Alta

Partners Alta Owned Company Details

What does Raptor Pharmaceutical Corp do?

Who are the key executives at Raptor Pharmaceutical Corp?

Partners Alta is the other: Former 10% owner of Raptor Pharmaceutical Corp. Other key executives at Raptor Pharmaceutical Corp include Chief Medical Officer Krishna R Polu , Chief Financial Officer Michael P Smith , and Chief Commercial Officer David Happel .

Raptor Pharmaceutical Corp (RPTP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Raptor Pharmaceutical Corp (RPTP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Raptor Pharmaceutical Corp (RPTP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Raptor Pharmaceutical Corp (RPTP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Raptor Pharmaceutical Corp Insider Transactions

No Available Data

What does Dynavax Technologies Corp do?

Who are the key executives at Dynavax Technologies Corp?

Partners Alta is the other: No longer 10% Owner of Dynavax Technologies Corp. Other key executives at Dynavax Technologies Corp include Principal Accounting Officer Justin Burgess , Chief Medical Officer and VP Robert Janssen , and Senior Vice President David F Novack .

Dynavax Technologies Corp (DVAX) Insider Trades Summary

Over the past 18 months, Partners Alta made no insider transaction in Dynavax Technologies Corp (DVAX). Other recent insider transactions involving Dynavax Technologies Corp (DVAX) include a net sale of 169,000 shares made by David F Novack , a net sale of 46,327 shares made by Robert Janssen , and a net sale of 3,000,000 shares made by Hack Andrew A. F. .

In summary, during the past 3 months, insiders sold 0 shares of Dynavax Technologies Corp (DVAX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,247,529 shares of Dynavax Technologies Corp (DVAX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,247,529 shares.

Dynavax Technologies Corp (DVAX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Dynavax Technologies Corp Insider Transactions

No Available Data

What does Cutera Inc do?

Who are the key executives at Cutera Inc?

Partners Alta is the 10 percent owner of Cutera Inc. Other key executives at Cutera Inc include EVP & Chief Technology Officer Michael Karavitis , Interim Chief Financial Office Stuart Drummond , and Chief Operating Officer Jeffrey S Jones .

Cutera Inc (CUTR) Insider Trades Summary

Over the past 18 months, Partners Alta made no insider transaction in Cutera Inc (CUTR). Other recent insider transactions involving Cutera Inc (CUTR) include a net sale of 63,603 shares made by Michael Karavitis , a net purchase of 30,000 shares made by Taylor C. Harris , and a net purchase of 5,000 shares made by Stuart Drummond .

In summary, during the past 3 months, insiders sold 0 shares of Cutera Inc (CUTR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 63,603 shares of Cutera Inc (CUTR) were sold and 35,000 shares were bought by its insiders, resulting in a net sale of 28,603 shares.

Cutera Inc (CUTR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cutera Inc Insider Transactions

No Available Data

What does Cyclacel Pharmaceuticals Inc do?

Who are the key executives at Cyclacel Pharmaceuticals Inc?

Partners Alta is the 10 percent owner of Cyclacel Pharmaceuticals Inc. Other key executives at Cyclacel Pharmaceuticals Inc include director & President & C.E.O. Spiro Rombotis , director & E.V.P. & Finance & C.O.O. Paul Mcbarron , and Chief Medical Officer Mark Kirschbaum .

Cyclacel Pharmaceuticals Inc (CYCC) Insider Trades Summary

Over the past 18 months, Partners Alta made no insider transaction in Cyclacel Pharmaceuticals Inc (CYCC). Other recent insider transactions involving Cyclacel Pharmaceuticals Inc (CYCC) include a net purchase of 6,070 shares made by Spiro Rombotis , and a net purchase of 1,886 shares made by Paul Mcbarron .

In summary, during the past 3 months, insiders sold 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) were sold and 7,956 shares were bought by its insiders, resulting in a net purchase of 7,956 shares.

Cyclacel Pharmaceuticals Inc (CYCC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cyclacel Pharmaceuticals Inc Insider Transactions

No Available Data

What does Rigel Pharmaceuticals Inc do?

Who are the key executives at Rigel Pharmaceuticals Inc?

Partners Alta is the 10 percent owner of Rigel Pharmaceuticals Inc. Other key executives at Rigel Pharmaceuticals Inc include EVP & Chief Financial Officer Dean L Schorno , Sr VP of Bus Dev and Com Ops Raul R Rodriguez , and EVP & Chief Commercial Officer David A Santos .

Rigel Pharmaceuticals Inc (RIGL) Insider Trades Summary

Over the past 18 months, Partners Alta made no insider transaction in Rigel Pharmaceuticals Inc (RIGL). Other recent insider transactions involving Rigel Pharmaceuticals Inc (RIGL) include a net sale of 52,894 shares made by Raul R Rodriguez , a net sale of 14,519 shares made by David A Santos , and a net sale of 12,628 shares made by Dean L Schorno .

In summary, during the past 3 months, insiders sold 0 shares of Rigel Pharmaceuticals Inc (RIGL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 8,004 shares of Rigel Pharmaceuticals Inc (RIGL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 8,004 shares.

Rigel Pharmaceuticals Inc (RIGL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Rigel Pharmaceuticals Inc Insider Transactions

No Available Data

What does Avadel Pharmaceuticals PLC do?

Who are the key executives at Avadel Pharmaceuticals PLC?

Partners Alta is the 10 percent owner of Avadel Pharmaceuticals PLC. Other key executives at Avadel Pharmaceuticals PLC include Chief Financial Officer Thomas S Mchugh , director & Chief Executive Officer Greg J Divis , and Chief Commercial Officer Richard J Kim .

Avadel Pharmaceuticals PLC (AVDL) Insider Trades Summary

Over the past 18 months, Partners Alta made no insider transaction in Avadel Pharmaceuticals PLC (AVDL). Other recent insider transactions involving Avadel Pharmaceuticals PLC (AVDL) include a net sale of 103,975 shares made by Mark Anthony Mccamish , a net purchase of 4,000 shares made by Thomas S Mchugh , and a net purchase of 14,000 shares made by Geoffrey Michael Glass .

In summary, during the past 3 months, insiders sold 0 shares of Avadel Pharmaceuticals PLC (AVDL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 103,975 shares of Avadel Pharmaceuticals PLC (AVDL) were sold and 41,000 shares were bought by its insiders, resulting in a net sale of 62,975 shares.

Avadel Pharmaceuticals PLC (AVDL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Avadel Pharmaceuticals PLC Insider Transactions

No Available Data

Partners Alta Mailing Address

Above is the net worth, insider trading, and ownership report for Partners Alta. You might contact Partners Alta via mailing address: One Embarcadero Center, Ste 3700, San Francisco Ca 94111.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.